Detalhe da pesquisa
1.
Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Haematologica
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779719
2.
A balancing act: Blinatumomab use in a rare occurrence of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in an adolescent patient with Down syndrome.
Pediatr Blood Cancer
; 70(5): e30191, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602024
3.
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.
Cancers (Basel)
; 15(7)2023 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046645
4.
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Cancers (Basel)
; 14(1)2021 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008312
5.
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia.
Blood Adv
; 5(23): 5215-5219, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592761